Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date |
Reported DateTime |
Exercisable Expiration |
Company | Symnbol | Insider Relationship |
Shares Traded |
Conversion Price |
Shares Owned |
Filing |
| 2025-03-07 Option Award |
2025-03-11 5:48 pm |
N/A 2035-03-07 |
Aquestive Therapeutics Inc. | AQST | Kraus Carl N Chief Medical Officer |
100,000 | $0 | 343,566 (Direct) |
View |
| 2025-03-07 Tax Withholding |
2025-03-11 5:48 pm |
N/A N/A |
Aquestive Therapeutics Inc. | AQST | Kraus Carl N Chief Medical Officer |
8,115 | $2.65 | 343,566 (Direct) |
View |
| 2024-08-09 Tax Withholding |
2024-08-12 2:45 pm |
N/A N/A |
Aquestive Therapeutics Inc. | AQST | Kraus Carl N Chief Medical Officer |
10,819 | $3.43 | 251,681 (Direct) |
View |
| 2024-03-07 Option Award |
2024-03-11 10:35 am |
N/A 2034-03-07 |
Aquestive Therapeutics Inc. | AQST | Kraus Carl N Chief Medical Officer |
168,750 | $0 | 318,750 (Direct) |
View |
| 2023-08-09 Option Award |
2023-08-09 4:30 pm |
N/A N/A |
Aquestive Therapeutics Inc. | AQST | Kraus Carl N Chief Medical Officer |
150,000 | $0 | 150,000 (Direct) |
View |
Ownership |
2023-06-30 4:06 pm |
N/A N/A |
Aquestive Therapeutics Inc. | AQST | Kraus Carl N CHIEF MEDICAL OFFICER |
0 | $0 | 0 (Direct) |
View |
| 2023-01-20 Option Award |
2023-02-02 8:10 pm |
N/A 2033-01-20 |
Aceragen Inc. | ACGN | Kraus Carl N CHIEF MEDICAL OFFICER |
25,400 | $0 | 25,400 (Direct) |
View |
| 2023-01-17 Exercise |
2023-01-19 9:46 pm |
N/A 2032-02-09 |
Aceragen Inc. | ACGN | Kraus Carl N Chief Medical Officer |
440,844 | $0 | 440,844 (Direct) |
View |
| 2022-09-28 Option Award |
2022-09-30 9:48 pm |
N/A 2032-02-09 |
IDERA PHARMACEUTICALS INC. | IDRA | Kraus Carl N Chief Medical Officer |
665,050 | $0 | 665,050 (Direct) |
View |